Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Microbot Medical Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +5 vs. Q4 2022
- Shares held
- 1.42M
- −72.8K (−4.9%) vs. Q4 2022
- Total value
- $2.94M
- −$1.54M (−34.3%) vs. Q4 2022
- New holders
- 6
- 7 more added
- Sold out
- 1
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $22.1M |
| Q1 2026 | 79 | $34.3M |
| Q4 2025 | 71 | $22.8M |
| Q3 2025 | 68 | $27.4M |
| Q2 2025 | 50 | $11.1M |
| Q1 2025 | 44 | $3.26M |
| Q4 2024 | 39 | $1.24M |
| Q3 2024 | 26 | $933.4K |
| Q2 2024 | 36 | $1.11M |
| Q1 2024 | 33 | $1.77M |
| Q4 2023 | 36 | $2.49M |
| Q3 2023 | 31 | $1.40M |
| Q2 2023 | 28 | $3.36M |
| Q1 2023 | 29 | $2.94M |
| Q4 2022 | 24 | $4.48M |
| Q3 2022 | 23 | $3.84M |
| Q2 2022 | 25 | $3.60M |
| Q1 2022 | 27 | $4.65M |
| Q4 2021 | 27 | $6.10M |
| Q3 2021 | 25 | $5.47M |
| Q2 2021 | 29 | $6.00M |
| Q1 2021 | 25 | $6.77M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Microbot Medical Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 300 | $0 | 0.00% | +300 | New |
| Front Row Advisors LLC | 1 | $0 | 0.00% | +1 | New |
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Pacific Center for Financial Services | 1 | $3 | 0.00% | +1 | New |
| Bank of America Corp | 2 | $4 | 0.00% | −8−80.0% | Reduced |
| Bourgeon Capital Management LLC | 11 | $23 | 0.00% | −2−15.4% | Reduced |
| Wells Fargo & Company | 187 | $390 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 571 | $1.00K | 0.00% | +570+57,000.0% | Added |
| Ameritas Advisory Services, LLC | 1,473 | $3.06K | 0.00% | +1,473 | New |
| Advisor Group Holdings, Inc. | 2,917 | $6.07K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,547 | $9.46K | 0.00% | +2,980+190.2% | Added |
| Tower Research Capital LLC (TRC) | 5,289 | $11.0K | 0.00% | +1,567+42.1% | Added |
| Steward Partners Investment Advisory, LLC | 5,800 | $12.1K | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 10,101 | $21.0K | 0.00% | −900−8.2% | Reduced |
| Northern Trust Corp | 13,446 | $28.0K | 0.00% | +3,017+28.9% | Added |
| Millennium Management LLC | 14,862 | $31.0K | 0.00% | +14,862 | New |
| Bank of New York Mellon Corp | 15,392 | $32.0K | 0.00% | −150−1.0% | Reduced |
| Renaissance Technologies LLC | 20,395 | $42.0K | 0.00% | +2,400+13.3% | Added |
| Citadel Advisors LLC | 23,243 | $48.3K | 0.00% | +23,243 | New |
| State Street Corp | 26,070 | $54.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 39,089 | $81.3K | 0.00% | +2,751+7.6% | Added |
| Geode Capital Management, LLC | 52,922 | $110.1K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 66,207 | $137.7K | 0.00% | −26,248−28.4% | Reduced |
| AlphaCentric Advisors LLC | 100,000 | $208.0K | 0.14% | 00.0% | Unchanged |
| BlackRock Inc. | 152,554 | $317.3K | 0.00% | +474+0.3% | Added |
| Vanguard Group Inc | 260,823 | $542.5K | 0.00% | −9,096−3.4% | Reduced |
| Armistice Capital, LLC | 600,000 | $1.25M | 0.03% | −90,000−13.0% | Reduced |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |